Download PDF
Exp Clin Endocrinol Diabetes 2004; 112(3): 142-147
DOI: 10.1055/s-2004-817823
Article

J. A. Barth Verlag in Georg Thieme Verlag Stuttgart · New York

Vascular Smooth Muscle Cells (VSMC) Proliferation of Streptozotocin-Diabetic Animals Induced by Diadenosine Polyphosphates

E. J. Verspohl1 , J. Hagemann1 , M. Lempka1
  • 1Institute of Pharmaceutical and Medicinal Chemistry, Department of Pharmacology, University of Münster, Münster, Germany
Further Information

Publication History

Received: January 27, 2003 First decision: April 28, 2003

Accepted: October 6, 2003

Publication Date:
30 March 2004 (online)

Also available at
    Permissions and Reprints

Abstract

Specific binding sites for diadenosine polyphosphates (Ap4A, Ap5A, Ap6A) exist in VSMC (cultured vascular smooth muscle cells). These compounds may regulate VSMC growth and proliferation which is a key event in atherogenesis. Since diabetes is a known risk factor for atherosclerosis, the proliferation of VSMC from normoglycemic (control) and hyperglycemic (diabetic) rats were compared and the possibly involved receptors for diadenosine polyphosphates inducing this effect were investigated. Diabetes was induced by streptozotocin (66 mg/kg i.p.) and VSMC were prepared from rat aorta (primary culture). (3H)thymidine incorporation was a measure of cell proliferation. For all diadenosine polyphosphates tested a stimulatory effect was observed as a bell-shaped concentration-response curve and a maximum effect at 10 µM (physiological concentration). Ap6A has the most prominent effect (247.8 ± 33.2 % increase over basal). In VSMC of diabetic rats the effects were even more prominent (Ap5A: 430.1 ± 62.7 %). ATP (a degradation product of Ap6A) is able to increase the maximum effect of 10 µM Ap6A. UTP (P2Y2 agonist) exhibits a weaker proliferation. 1 µM suramin (P2 receptor antagonist) shifts the concentration response curve of ATP and of Ap6A to the right. In contrast, 10 µM PPADS (P2 X receptor antagonist) has no effect. There is no difference between VSMC of normal and diabetic rats in this respect. ADP, AMP, and adenosine exhibit a dual proliferative effect. The effect of either of these 3 compounds is much higher in VSMC of diabetic rats than of controls. 2MeSATP (P2Y1 agonist) and α,β-Methylen-ATP (P2X agonist) were not effective in VSMC of both normoglycemic and diabetic rats. In conclusion: The proliferative effect of diadenosine polyphosphates and some degradation products is more pronounced in VSMC of diabetic than of normal rats. Ap6A acts maximally by itself and not by its degradation product ATP. Adenosine receptors or an unknown P2YApxA receptor may be involved in proliferative effects, but not P2X and P2Y1 receptors irrespective of a diabetic situation.

Key words

Diadenosine polyphosphates - VSMC - proliferation - streptozotocin-diabetic animals

References

  • 1 Blackburn G M, Taylor G E, Thatcher G R, Prescott M, McLennan A G. Synthesis and resistance to enzymic hydrolysis of stereochemically-defined phosphonate and thiophosphate analogs of P1, P4-bis(5′-adenosyl) tetraphosphate.  Nucleic Acids Res. 1987;  15 6991-7004
    PubMedGoogle Scholar
  • 2 Chen Z P, Krull N, Xu S, Levy A, Lightman S L. Molecular cloning and functional characterization of a rat pituitary G protein-coupled adenosine triphosphate (ATP) receptor.  Endocrinology. 1996;  137 1833-1840
    CrossrefPubMedGoogle Scholar
  • 3 Davies G, MacAllister R J, Bogle R G, Vallance P. Effects of diadenosine polyphosphates on human umbilical vessels: novel platelet-derived vasoconstrictors.  Br J Clin Pharmacol. 1995;  40 170-172
    PubMedGoogle Scholar
  • 4 Dubey R K, Gillespie D G, Osaka K, Suzuki F, Jackson E K. Adenosine inhibits growth of rat aortic smooth muscle cells. Possible role of A2b receptor.  Hypertension. 1996;  27 786-793
    PubMedGoogle Scholar
  • 5 Edgecombe M, McLennan A G, Fisher M J. Characterization of the binding of diadenosine 5′, 5‘’-P1, P4-tetraphosphate (Ap4A) to rat liver cell membranes.  Biochem J. 1996;  314 687-693
    PubMedGoogle Scholar
  • 6 Erlinge D. Extracellular ATP: a growth factor for vascular smooth muscle cells.  Gen Pharmacol. 1998;  31 1-8
    CrossrefPubMedGoogle Scholar
  • 7 Erlinge D, You J, Wahlestedt C, Edvinsson L. Characterisation of an ATP receptor mediating mitogenesis in vascular smooth muscle cells.  Eur J Pharmacol. 1995;  289 135-149
    PubMedGoogle Scholar
  • 8 Hilderman R H, Martin M, Zimmerman J K, Pivorun E B. Identification of a unique membrane receptor for adenosine 5′, 5‘’‘-P1, P4-tetraphosphate.  J Biol Chem. 1991;  266 6915-6918
    PubMedGoogle Scholar
  • 10 Hoyle C HV, Ziganshin A U, Pintor J, Burnstock G. The activation of P1- and P2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates.  Br J Pharmacol. 1996;  118 1294-1301
    PubMedGoogle Scholar
  • 11 Jankowski J, Hagemann J, Tepel M, van Der Giet M, Stephan N, Henning L, Gouni-Berthold I, Sachinidis A, Zidek W, Schlüter H. Dinucleotides as growth-promoting extracellular mediators. Presence of dinucleoside diphosphates Ap2A, Ap2G, and Gp2G in releasable granules of platelets.  J Biol Chem. 2001;  279 8904-8909
    PubMedGoogle Scholar
  • 12 Kawano M, Koshikawa T, Kanazaki T, Morisaki N, Saito Y, Yoshida S. Diabetes mellitus induces accelerated growth of aortic smooth muscle cells: association with overexpression of PDGF beta-receptors.  Eur J Clin Invest. 1993;  23 84-90
    CrossrefPubMedGoogle Scholar
  • 13 Lazarowski E R, Watt W C, Stutts M J, Boucher R C, Harden T K. Pharmacological selectivity of the cloned human P2U - purinoceptor: potent activation by diadenosine tetraphosphate.  Br J Pharmacol. 1995;  116 1619-1627
    PubMedGoogle Scholar
  • 14 Meyer-Lehnert H, Schrier R W. Potential mechanism of cyclosporine A-induced vascular muscle contraction.  Hypertension Dallas. 1989;  13 352-360
    PubMedGoogle Scholar
  • 15 Ogilvie A, Blasius R, Schulze-Lohoff E, Sterzel R B. Adenine dinucleotides: a novel class of signalling molecules.  J Auton Pharmacol. 1996;  16 325-328
    PubMedGoogle Scholar
  • 16 Parés-Herbuté N, Hillaire-Buys D, Etienne P, Gross R, Loubatieres-Mariani M M, Monnier L. Adenosine inhibitory effect on enhanced growth of aortic smooth muscle cells from streptozotocin-induced diabetic rats.  Br J Pharmacol. 1996;  118 783-789
    PubMedGoogle Scholar
  • 18 Rice W R, Burton F M, Fiedeldey D T. Cloning and expression of the alveolar type II cell P2U - purinergic receptor.  Am J Respir Cell Mol Biol. 1995;  12 27-32
    PubMedGoogle Scholar
  • 19 Rodriguez-Pascual F, Cortes R, Torres M, Palacios J M, Miras-Portugal M T. Distribution of [3H]diadenosine tetraphosphate binding sites in rat brain.  Neuroscience. 1997;  77 247-255
    CrossrefPubMedGoogle Scholar
  • 20 Rupprecht H D, Dann P, Sukhatme V P, Sterzel R B, Coleman D L. Effect of vasoactive agents on induction of Egr-1 in rat mesangial cells: correlation with mitogenicity.  Am J Physiol. 1992;  263 F623-636
    PubMedGoogle Scholar
  • 21 Schlüter H, Offers E, Brüggemann G, van der Giet M, Tepel M, Nordhoff E, Karas M, Spieker C, Witzel H, Zidek W. Diadenosine phosphates and the physiological control of blood pressure.  Nature. 1994;  367 187-188
    PubMedGoogle Scholar
  • 22 Schlüter H, Tepel M, Zidek W. Vascular actions of diadenosine polyphosphates.  J Autonomic Pharmacology. 1996;  16 357-362
    PubMedGoogle Scholar
  • 23 Schulze-Lohoff E, Zanner S, Ogilvie A, Sterzel R B. Vasoactive diadenosine polyphosphates promote growth of cultured renal mesangial cells.  Hypertension. 1995;  26 899-904
    PubMedGoogle Scholar
  • 25 Sukhatme V P, Cao X M, Chang L C, Tsai-Morris C H, Stamenkovich D, Ferreira P C, Cohen D R, Edwards S A, Shows T B, Curran T. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization.  Cell. 1988;  53 37-73
    CrossrefPubMedGoogle Scholar
  • 26 Tepel M, Bachmann J, Schlüter H, Zidek W. Diadenosine polyphosphate-induced increase in cytosolic free calcium in vascular smooth muscle cells.  J Hypertension. 1995;  13 1686-1688
    PubMedGoogle Scholar
  • 27 Tepel M, Bachmann J, Schlüter H, Zidek W. Diadenosine polyphosphates increase cytosolic calcium and attenuate angiotensin-II-induced changes of calcium in vascular smooth muscle cells.  J Vasc Res. 1996;  33 132-138
    PubMedGoogle Scholar
  • 28 Tepel M, Jankowski J, Schlüter H, Bachmann J, van der Giet M, Rüss C, Terliesner J, Zidek W. Diadenosine polyphosphates' action on calcium and vessel contraction.  Am J Hypertens. 1997;  10 1404-1410
    PubMedGoogle Scholar
  • 29 Vahlensieck U, Boknik P, Knapp J, Linck B, Müller F U, Neumann J, Herzig S, Schlüter H, Zidek W, Deng M C, Scheld H H, Schmitz W. Negative chronotropic and inotropic effects by diadenosine hexaphosphate (Ap6A) via A1-adenosine receptors.  Br J Pharmacol. 1996;  119 835-844
    PubMedGoogle Scholar
  • 31 Verspohl E J, Johannwille B. Diadenosine polyphosphates in insulin-secreting cells: Interaction with specific receptors and degradation.  Diabetes. 1998;  47 1727-1734
    PubMedGoogle Scholar
  • 32 Verspohl E J, Johannwille B, Kaiserling-Buddemeier I, Schlüter H, Hagemann J. Diadenosine polyphosphates in cultured vascular smooth muscle cells and endothelium cells-their interaction with specific receptors and their degradation.  J Pharm Pharmacol. 1999;  51 1175-1181
    CrossrefPubMedGoogle Scholar
  • 33 Verspohl E J, Hohmeier N, Lempka M. Diadenosine tetraphosphate (Ap4A) induces a diabetogenic situation: its impact on blood glucose, plasma insulin, gluconeogenesis, glucose uptake and GLUT-4 transporters.  Die Pharmazie. 2003 a;  58 910-915
    PubMedGoogle Scholar
  • 34 Verspohl E J, Schlüter H, Zidek W. Long-term effects of diadenosine polyphosphates on blood pressure, heart rate, glucose and insulin levels of rats.  Medicinal Chemistry Research. 2003 b;  (in press)
    PubMedGoogle Scholar
  • 35 Walker J, Bossman P, Lackey B R, Zimmermann J K, Dimmick M A, Hilderman R H. The adenosine 5′, 5′′′, P1, P4-tetraphosphate receptor is at the cell surface of heart cells.  Biochemistry. 1993;  32 14009-14014
    CrossrefPubMedGoogle Scholar
  • 36 Wang R, Kudo M, Naito Z, Yokoyama M, Yamada N, Asano G. Effects of serum of streptozotocin-induced diabetic rats on vascular smooth muscle cell growth in vitro.  Nippon Ika Daigaku Zasshi Aug. 1998;  65 284-290
    PubMedGoogle Scholar
  • 37 Yu S M, Chen S F, Lau Y T, Yang C M, Chen J C. Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.  Mol Pharmacol. 1996;  50 1000-1009
    PubMedGoogle Scholar

Dr. E. J. Verspohl

Department of Pharmacology · Institute of Pharmaceutical and Medicinal Chemistry

Hittorfstraße 58 - 62

48149 Münster

Germany

Phone: + 492518333339

Fax: + 49 25 18 33 21 44

Email: verspoh@uni-muenster.de